The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.

This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.

View Congress Resources by Therapeutic Area
PLEASE NOTE: Materials will be available on a rolling basis after individual embargoes are lifted. Audio abstracts are generated using text-to-speech software and contain an audio version of the abstract that was submitted and accepted as part of the official conference materials.
Showing 6 of 36 results
Sort by date: Descending
Encores: Not included
US Psych Congress Annual
September 7th – 10th 2023
Schizophrenia
POSTER
Baseline Demographics and Clinical Characteristics From OASIS: Observational Study of Long-Acting Injectables in Schizophrenia
AUTHOR(S)

Lauren N. Strand,1 Michael J. Doane,1 Christina Arevalo,1 James A. McGrory,1 Peter J. Weiden,2 Eric D. Achtyes,3 Phillip D. Harvey,4 John M. Kane,5 Stephen R. Saklad,6 Jeffrey Trotter,7 Dawn I. Velligan8

View poster
Schizophrenia
Bipolar Disorder
POSTER
Burden of Bipolar I Disorder on Clinical, Economic, and Humanistic Outcomes: Matched Analysis of US National Health and Wellness Survey Data
AUTHOR(S)

Michael J. Doane,1 Adam Jauregui,2 Hemangi Panchmatia1

View poster
Bipolar Disorder
Bipolar Disorder
Schizophrenia
POSTER
Healthcare Resource Utilization Following 6 Months of Treatment With Olanzapine/Samidorphan: Real-World Assessment of Patients With Schizophrenia or Bipolar I Disorder
AUTHOR(S)

Rakesh Jain,1 Hemangi R. Panchmatia,2 Alejandro G. Hughes,3 Noah S. Webb,3 Michael J. Doane,2 Andrew J. Cutler4,5

View poster
Bipolar Disorder
Schizophrenia
Alcohol Use Disorder
POSTER
Mental Health Comorbidities Among Patients With Chronic Medical Conditions and Alcohol Use Disorder
AUTHOR(S)

Lauren Strand,1 Regina Grebla,1 Summera Zhou,2 Xin Zhao,2 Allison Keshishian,2 Monica McClain,2 Sandra Springer3

View poster
Alcohol Use Disorder
American Society of Clinical Psychopharmacology
May 30th – June 2nd 2023
Bipolar Disorder
Schizophrenia
POSTER
Olanzapine/Samidorphan Effects on Weight Gain: A Meta-analysis of Phase 2 and 3 Randomized, Double-Blind Studies
AUTHOR(S)

Christoph Correll,1-3 Michael J. Doane,4 David McDonnell,5 Meihua Wang,4 Sarah Akerman,4 S. Stephen R. Saklad6

View poster
Bipolar Disorder
Schizophrenia
Schizophrenia International Research Society
May 11th – 15th 2023
Bipolar Disorder
Schizophrenia
POSTER
Preferences for Characteristics of Oral Antipsychotic Treatments: Survey Results of Patients Living With Schizophrenia or Bipolar I Disorder
AUTHOR(S)

Michael J. Doane,1 Marco Boeri,2,3 Caroline Vass,4,5 Cooper Bussberg,6 Hemangi R. Panchmatia,1 Sabina Gasper,1 Leslie Citrome,7 Martha Sajatovic8

View poster
Bipolar Disorder
Schizophrenia